[HTML][HTML] Moyamoya disease: treatment and outcomes

T Kim, CW Oh, JS Bang, JE Kim, WS Cho - Journal of stroke, 2016 - ncbi.nlm.nih.gov
Although the pathogenesis of moyamoya disease (MMD) has not been fully elucidated, the
effectiveness of surgical revascularization in preventing stroke has been addressed by many …

[HTML][HTML] The pathophysiology of moyamoya disease: an update

OY Bang, M Fujimura, SK Kim - Journal of stroke, 2016 - ncbi.nlm.nih.gov
Moyamoya disease (MMD) is a unique cerebrovascular disease characterized by the
progressive stenosis of large intracranial arteries and a hazy network of basal collaterals …

2021 Japanese guidelines for the management of Moyamoya disease: guidelines from the research committee on Moyamoya disease and Japan stroke society

M Fujimura, T Tominaga, S Kuroda… - Neurologia medico …, 2022 - jstage.jst.go.jp
1Department of Neurosurgery, Hokkaido University Graduate School of Medicine, Sapporo,
Hokkaido, Japan 2Department of Neurosurgery, Tohoku University Graduate School of …

The frequency of postoperative stroke in moyamoya disease following combined revascularization: a single-university series and systematic review

K Kazumata, M Ito, K Tokairin, Y Ito, K Houkin… - Journal of …, 2014 - thejns.org
Object Although combined direct and indirect anastomosis in patients with moyamoya
disease immediately increases cerebral blood flow, the surgical procedure is more complex …

Moyamoya Disease Susceptibility Gene RNF213 Regulates Endothelial Barrier Function

V Roy, JP Ross, R Pépin, S Cortez Ghio, A Brodeur… - Stroke, 2022 - Am Heart Assoc
Background: Variants in the ring finger protein 213 (RNF213) gene are known to be
associated with increased predisposition to cerebrovascular diseases development …

Moyamoya disease

M Fujimura, OY Bang, JS Kim - … : Pathophysiology, Diagnosis and …, 2016 - karger.com
Moyamoya disease (MMD) is a chronic occlusive cerebrovascular disease characterized by
progressive stenosis at the terminal portion of the internal carotid artery and an abnormal …

Moyamoya Disease and Spectrums of RNF213 Vasculopathy

OY Bang, JW Chung, DH Kim, HH Won… - Translational stroke …, 2020 - Springer
Moyamoya disease (MMD) is a rare cerebrovascular disease characterized by progressive
stenosis of large intracranial arteries and a hazy network of basal collaterals called …

Predictors and clinical features of postoperative hyperperfusion after surgical revascularization for moyamoya disease: a serial single photon emission CT/positron …

H Uchino, S Kuroda, K Hirata, T Shiga, K Houkin… - Stroke, 2012 - Am Heart Assoc
Background and Purpose—Clinical features and pathophysiology of postoperative
hyperperfusion in moyamoya disease are still unclear. This study was aimed to clarify the …

[HTML][HTML] Genetics and biomarkers of moyamoya disease: significance of RNF213 as a susceptibility gene

M Fujimura, S Sonobe, Y Nishijima, K Niizuma… - Journal of …, 2014 - ncbi.nlm.nih.gov
Moyamoya disease is characterized by a progressive stenosis at the terminal portion of the
internal carotid artery and an abnormal vascular network at the base of the brain. Although …

Imaging of moyamoya disease and moyamoya syndrome: current status

J Li, M Jin, X Sun, J Li, Y Liu, Y Xi, Q Wang… - Journal of Computer …, 2019 - journals.lww.com
Moyamoya disease (MMD) and Moyamoya syndrome (MMS) are referring to a progressive
steno-occlusive vasculopathy at terminal portions of the bilateral internal carotid arteries and …